T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
about
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infectionT cells with regulatory activity in hepatitis C virus infection: what we know and what we don'tDifferential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core proteinCostimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis CTim-3 negatively regulates IL-12 expression by monocytes in HCV infection.Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.Study of human B7 homolog 1 expression in patients with hepatitis B virus infectionComparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNAHepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.Viral modulation of T-cell receptor signalingHemoglobin subunit beta interacts with the capsid protein and antagonizes the growth of classical swine fever virus.Immune gene expression in swine macrophages expressing the Torque Teno Sus Virus1 (TTSuV1) ORF-1 and 2 proteins.Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.Changes in immune cell populations in the periphery and liver of GBV-B-infected and convalescent tamarins (Saguinus labiatus)Immunity and immunopathology to viruses: what decides the outcome?Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection.Lack of strong anti-viral immune gene stimulation in Torque Teno Sus Virus1 infected macrophage cellsMolecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek's disease virus.PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection.Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma.PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection.Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.Insufficiency of DNA repair enzyme ATM promotes naive CD4 T-cell loss in chronic hepatitis C virus infection.Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy.
P2860
Q26750997-081713BA-74DE-4079-90EA-189CF1E66393Q27331338-8BB36433-ED56-4FA6-9929-D5DA0881B21EQ27486637-F675EA1E-F750-4E5A-83EE-75C47BFD4747Q27487006-6ACA10CD-C884-4426-AEED-E1DE6C78D0AEQ27490355-71AD3247-26A1-402A-9D78-8DBC6CB922FFQ30432023-E871B6ED-8BAE-4D3B-849B-BF7590D65972Q34259893-48AFC11A-B3FD-456F-947D-7D1B2A614411Q34311546-41A292FB-51FE-46F7-8A03-B75A71E5158BQ34783795-A9BBDB87-8460-45E7-A360-79BBDFE475A2Q34955808-AD5C22BD-44B4-40F6-87CD-5FF8B0552E1FQ34960553-AF11AFE0-57BD-4185-80E9-DA2B94B2E67CQ36121216-DC67DDE1-B532-48BD-B0AE-BC5885202ABCQ36280098-D99E4255-8F7C-49E6-A6C5-DEBD610680D1Q36428322-C2ED5CED-7897-43F1-82E7-BF6473F04EFEQ36540182-370CAC4E-4EC6-455A-8811-FCA04017A8BCQ36827352-EDFF574E-3D26-4276-9E5C-82A782FB51E2Q36984301-6A149FCB-6127-494E-AEE7-0F33BAC45911Q37406571-C75EEF5B-420F-4553-B057-650DBFBF5EABQ37671532-2B623E17-1779-46A4-9B1B-2FC3E36F3DBDQ37767587-9E5FEB0F-6C9A-46EC-881A-EF65EA0B9DD9Q38080732-FAB79F87-683B-4751-AD2F-98C57D0BBD77Q38770936-4DBB8A26-40E8-4B80-9E31-4929DD4FD234Q39345223-F880CED6-9322-4713-B7BD-DAB6A4C45D38Q41045077-AE249B81-B13E-4024-8DB7-96DA944B277EQ41198488-32716802-D419-4BB2-BA9C-1DEC6BE9B9C7Q42071282-032C6168-A073-4D2F-AEA3-03E7B7537616Q42585404-C7137E56-224C-4C0D-95C2-DD4D5AF75B7EQ45371124-E5714FBB-2946-4473-B8C9-784C69F15F18Q45381619-21BC1203-10F1-4BC8-B99D-B9D0E13AFA17Q52592808-01267122-C13F-46B7-B749-375E647ABA16Q55400314-153066A6-A031-4AB2-93F6-1678B35993D9
P2860
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@ast
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@en
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@nl
type
label
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@ast
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@en
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@nl
prefLabel
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@ast
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@en
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@nl
P2093
P356
P1433
P1476
T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
@en
P2093
Deborah Prayther
Deling Yin
Ellis King
Jonathan Moorman
P304
P356
10.1089/VIM.2006.0096
P577
2007-01-01T00:00:00Z